Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: The implication of a common progenitor cell?

Neuropathology

Volumn 33, Issue 3, 2013, Pages 246-255

  Matsumura, Nozomi ^a   Yokoo, Hideaki ^a   Mao, Ying ^b   Yin, Wang ^b   Nakazato, Yoichi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUDAN UNIVERSITY   (China)

Author keywords

Dysembryoplastic neuroepithelial tumor; Glioneuronal tumor; Olig2; Papillary glioneuronal tumor; Rosette forming glioneuronal tumor

Indexed keywords

ALPHA INTERNEXIN; CYCLIN D1; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLIONEURONAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROFILAMENT; NEUROPATHOLOGY; PAPILLARY GLIONEURONAL TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; ROSETTE FORMATION; ROSETTE FORMING GLIONEURONAL TUMOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; OLIGODENDROGLIA; ROSETTE FORMATION; STEM CELLS; YOUNG ADULT;

EID: 84878634823     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01355.x     Document Type: Article

References (40)

1. Brat DJ, VandenBerg SR, Figarella-Branger D, Taratuto AL. Desmoplastic infantile astrocytoma and ganglioglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumour of the Central Nervous System, 4th edn. Lyon: International Agency for Research on Cancer (IARC) Press, 2007; 96-98.
2. Daumas-Duport C, Pietsch T, Hawkins C, Shankar SK. Dysembryoplastic neuroepithelial tumour. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumour of the Central Nervous System, 4th edn. Lyon: International Agency for Research on Cancer (IARC) Press, 2007; 99-102.
3. Becker AJ, Wiestler OD, Figarella-Branger D, Blümcke I. Ganglioglioma and gangliocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumour of the Central Nervous System, 4th edn. Lyon: International Agency for Research on Cancer (IARC) Press, 2007; 103-105.
4. Nakazato Y, Figarella-Branger D, Becker AJ, Scheithauer BW, Rosenblum MK. Papillary glioneuronal tumour. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumour of the Central Nervous System, 4th edn. Lyon: International Agency for Research on Cancer (IARC) Press, 2007; 113-114.
5. Hainfellner JA, Scheithauer BW, Giangaspero F, Rosenblum MK. Rosette-forming glioneuronal tumour of the fourth ventricle. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumour of the Central Nervous System, 4th edn. Lyon: International Agency for Research on Cancer (IARC) Press, 2007; 115-116.
6. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988; 23: 545-556.
7. Komori T, Scheithauer BW, Anthony DC etal. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol 1998; 22: 1171-1183.
8. Komori T, Scheithauer BW, Hirose T. A rosette-forming glioneuronal tumor of the 4th ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol 2002; 26 (5): 582-591.
9. Chen L, Xu QZ, Piao YS etal. Dysembryoplastic neuroepithelial tumor: a clinicopathologic and immunohistochemical study [In Japanese with English abstract]. Zhonghua Bing Li Xue Za Zhi 2007; 36 (8): 524-528.
10. Preusser M, Budka H, Rössler K, Hainfellner JA. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms. Histopathology 2007; 50: 365-370.
11. Tanaka Y, Yokoo H, Komori T etal. A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype? Acta Neuropathol 2005; 110: 39-47.
12. Chen L, Piao YS, Xu QZ, Yang XP, Yang H, Lu DH. Papillary glioneuronal tumor: a clinicopathological and immunohistochemical study of two cases. Neuropathology 2006; 26: 243-248.
13. Gelpi E, Preusser M, Czech T, Slavc I, Prayer D, Budka H. Papillary glioneuronal tumor. Neuropathology 2007; 27: 468-473.
14. Izycka-Świeszewska E, Majewska H, Szurowska E, Mazurkiewicz-Betdzińska M, Drozyńska E. Papillary glioneuronal tumour of the precentral gyrus. Folia Neuropathol 2008; 46 (2): 158-163.
15. Faria C, Miguéns J, Antunes JL etal. Genetic alterations in a papillary glioneuronal tumor. J Neurosurg Pediatr 2008; 1: 99-102.
16. Wang Y, Xiong J, Chu SG etal. Rosette-forming glioneuronal tumor: report of an unusual case with intraventricular dissemination. Acta Neuropathol 2009; 118: 813-819.
17. Luan SH, Zhuang DX, Sun LL, Huang FP. Rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle: case report and review of literature. Clin Neurol Neurosurg 2010; 112: 362-364.
18. Xiong J, Liu Y, Chu SG etal. Rosette-forming glioneuronal tumor of the septum pellucidum with extension to the supratentorial ventricles: rare case with genetic analysis. Neuropathology 2012; 32: 301-305. doi: 10.1111/j.1440-1789.2011.01261.
19. Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y. The basic helix-loop-helix factor Olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol 2002; 12: 1157-1163.
20. Lu QR, Sun T, Zhu Z etal. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002; 109: 75-86.
21. Sauvageot CM, Stiles CD. Molecular mechanisms controlling cortical gliogenesis. Curr Opin Neurobiol 2002; 12: 244-249.
22. Zhu JJ, Xiong J, Wang Y etal. Rosette-forming glioneuronal tumor of fourth ventricle: report of two cases. Zhonghua Bing Li Xue Za Zhi 2009; 38 (12): 850-851.
23. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumour of the Central Nervous System, 4th edn. Lyon: International Agency for Research on Cancer (IARC) Press, 2007.
24. Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T. Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 1982; 46: 621-626.
25. Yamane Y, Hirato J, Sasaki A, Nakazato Y. A case of dysembryoplastic neuroepithelial tumor developed in the cerebellum [in Japanese with English abstract]. Brain Tumor Pathol Suppl 2000; 17: 86.
26. Durand B, Gao FB, Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 1997; 16 (2): 306-317.
27. Frederick TJ, Wood TL. IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells. Mol Cell Neurosci 2004; 25: 480-492.
28. Frederick TJ, Min J, Altieri SC, Mitchell NE, Wood TL. Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-I and FGF-2 requires differential stimulation of multiple signaling pathways. Glia 2007; 55: 1011-1022.
29. Lange C, Huttner WB, Calegari F. Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell 2009; 5: 320-331.
30. Hu JG, Wang YX, Wang HJ etal. PDGF-AA mediates B104CM-induced oligodendrocyte precursor cell differentiation of embryonic neural stem cells through Erk, PI3K, and p38 signaling. J Mol Neurosci 2012; 46: 644-653. doi: 10.1007/s12031-011-9652-x.
31. Shan MN, Leonard JR, Perry A. Rosette-forming glioneuronal tumors of the posterior fossa: report of 6 cases. J Neurosurg Pediatr 2010; 5: 98-103.
32. Edgar MA, Rosenblum MK. Mixed glioneuronal tumors: recently described entities. Arch Pathol Lab Med 2007; 131: 228-233.
33. Scholz M, Hoischen A, Radlwimmer B etal. Rosetted glioneuronal tumor of the spine with overtly anaplastic histological features. Acta Neuropathol 2009; 117: 591-593.
34. Ghosal N, Furtado SV, Hegde AS. Rosette forming glioneuronal tumor pineal gland and tectum: an intraoperative diagnosis on smear preparation. Diagn Cytopathol 2010; 38: 590-593.
35. Arai A, Sasayama T, Tamaki M etal. Rosette-forming glioneuronal tumor of the fourth ventricle. Neurol Med Chir (Tokyo) 2010; 50: 224-228.
36. Solis OE, Mehta RI, Lai A etal. Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases. J Neurooncol 2011; 102 (3): 477-484.
37. Chojnacki A, Kelly J, Hader W, Weiss S. Distinctions between fetal and adult human platelet-derived growth factor-responsive neural precursors. Ann Neurol 2008; 64: 127-142.
38. Wolf HK, Buslei R, Blümcke I, Wiestler OD, Pietsch T. Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors. Acta Neuropathol 1997; 94: 436-443.
39. Sung CO, Suh YI. Different pattern of expression of nestin in the non-specific form of dysembryoplastic neuroepithelial tumors compared to the simple and complex forms. J Neurooncol 2009; 92: 7-13.
40. Eigenbrod S, Roeber S, Thon N etal. α-internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status. J Neuropathol Exp Neurol 2011; 70 (11): 970-978.